ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.154,79
0,44%
S&P 500
5.221,42
-0,02%
US Dollar vs BRL
5,1554
-0,01%
Bitcoin
62.488,10
-0,66%
Brent Oil
83,225
0,02%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. AMEX
  6. AgeX Therapeutics Inc (AGE)

  7. AgeX Therapeutics Inc (AGE) Notícias

AGE

AgeX Therapeutics (AGE)

AgeX Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:AMEX:AGE
DataHoraFonteTítuloCódigoCompanhia
22/03/202418:27GlobeNewswire Inc.AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial ResultsAMEX:AGEAgeX Therapeutics Inc
07/03/202418:49Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsAMEX:AGEAgeX Therapeutics Inc
07/03/202418:47Edgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
07/03/202409:47Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
14/02/202402:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:AGEAgeX Therapeutics Inc
18/01/202419:29Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:AGEAgeX Therapeutics Inc
16/01/202411:11Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]AMEX:AGEAgeX Therapeutics Inc
15/11/202311:38Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:AGEAgeX Therapeutics Inc
14/11/202318:05Business WireAgeX Therapeutics Reports Third Quarter 2023 Financial ResultsAMEX:AGEAgeX Therapeutics Inc
07/11/202318:06Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:AGEAgeX Therapeutics Inc
22/09/202317:05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsAMEX:AGEAgeX Therapeutics Inc
30/08/202308:00Business WireSerina Therapeutics and AgeX Therapeutics Enter into Merger AgreementAMEX:AGEAgeX Therapeutics Inc
14/08/202317:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:AGEAgeX Therapeutics Inc
14/08/202317:05Business WireAgeX Therapeutics Reports Second Quarter 2023 Financial ResultsAMEX:AGEAgeX Therapeutics Inc
24/07/202319:28Business WireAgeX Therapeutics Closes $36,000,000 Debt Exchange for Preferred StockAMEX:AGEAgeX Therapeutics Inc
21/07/202318:32Business WireAgeX Therapeutics Announces $36,000,000 Debt Exchange for Preferred StockAMEX:AGEAgeX Therapeutics Inc
08/06/202317:06Edgar (US Regulatory)Current Report Filing (8-k)AMEX:AGEAgeX Therapeutics Inc
23/05/202317:05Business WireAgeX Therapeutics Announces Appeal of NYSE American DeterminationAMEX:AGEAgeX Therapeutics Inc
18/05/202317:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:AGEAgeX Therapeutics Inc
12/05/202317:05Business WireAgeX Therapeutics Reports First Quarter 2023 Financial ResultsAMEX:AGEAgeX Therapeutics Inc
26/04/202317:05Business WireAgeX Therapeutics Receives Stock Exchange Deficiency LetterAMEX:AGEAgeX Therapeutics Inc
31/03/202317:05Business WireAgeX Therapeutics Reports Fourth Quarter and Annual 2022 Financial ResultsAMEX:AGEAgeX Therapeutics Inc
22/03/202317:20Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:AGEAgeX Therapeutics Inc
22/03/202317:17Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:AGEAgeX Therapeutics Inc
06/02/202318:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)AMEX:AGEAgeX Therapeutics Inc
25/11/202217:41Business WireAgeX Therapeutics Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing RequirementsAMEX:AGEAgeX Therapeutics Inc
10/11/202218:21Edgar (US Regulatory)Quarterly Report (10-q)AMEX:AGEAgeX Therapeutics Inc
10/11/202218:05Business WireAgeX Therapeutics Reports Third Quarter 2022 Financial ResultsAMEX:AGEAgeX Therapeutics Inc
02/11/202217:48Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:AGEAgeX Therapeutics Inc
05/10/202217:07Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)AMEX:AGEAgeX Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:AMEX:AGE

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
ENJU3
Enjoei ON
BOV
TELB4
TELEBRAS PN
BOV
IRBR3
IRB BRASIL ON
BOV
POSI3
POSITIVO TEC ON
BOV
COGN3
COGNA ON
BOV
PRIO3
PETRORIO ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados